Tango Therapeutics | 4:持股变动声明- MVA Investors, LLC
Tango Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Southpoint Master Fund, LP(4.9%),Southpoint Capital Advisors LP(4.9%)等
Tango Therapeutics | 4:持股变动声明-股东 Third Rock Ventures IV, L.P.
Tango Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Southpoint Master Fund, LP(5.2%),Southpoint Capital Advisors LP(5.2%)等
Tango Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)
Tango Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-FMR LLC(9.596%),Abigail P. Johnson(9.596%)
Tango Therapeutics | 4:持股变动声明-高管 Weber Barbara
Tango Therapeutics | 4:持股变动声明-高管 Barry Douglas
Tango Therapeutics | 4:持股变动声明-高管 Beckman Daniella
Tango Therapeutics | 4:持股变动声明-高管 Crystal Adam
Tango Therapeutics | 4:持股变动声明-高管 Beckman Daniella
Tango Therapeutics | 4:持股变动声明-高管 Crystal Adam
Tango Therapeutics | 4:持股变动声明-高管 Barry Douglas
Tango Therapeutics | 4:持股变动声明-高管 Weber Barbara
Tango Therapeutics | 3:首次持股声明-董事 Pothula Kanishka
Tango Therapeutics | 4:持股变动声明-高管 Crystal Adam
Tango Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Joe Lewis(15.0%),Boxer Capital, LLC(8.1%)等
Tango Therapeutics | 4/A:持股变动声明(修正)- Boxer Capital, LLC
Tango Therapeutics | 4:持股变动声明- Boxer Capital, LLC
Tango Therapeutics | 3:首次持股声明-股东 EcoR1 Capital, LLC
暂无数据